trending Market Intelligence /marketintelligence/en/news-insights/trending/ikfak80yi9qcpzs474ftbg2 content esgSubNav
In This List

Bellicum Pharmaceuticals adds former Pfizer exec to board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bellicum Pharmaceuticals adds former Pfizer exec to board

Houston-based biotech company Bellicum Pharmaceuticals Inc. appointed Edmund Harrigan to its board.

Harrigan most recently served as the senior vice president of worldwide safety and regulatory at Pfizer Inc.

He has 28 years of industry experience in clinical development, regulatory affairs and business development.

Bellicum CEO Rick Fair said Harrigan's addition will be "instrumental" as the company develops treatments for cancers and rare blood disorders.